AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2132417 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 W exercise treatment
Number of subjects: 9
Study 2132417 — intervention group
Group type: EXPERIMENTAL
Intervention: 175 W exercise treatment
Number of subjects: 9
Study 2132417 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 9
Study 927305 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug B (Dihydrocodeine, Remedacen)
Number of subjects: 0
Study 927305 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug A (Codeine, Phenyltoloxamine)
Number of subjects: 0
Study 30640308 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Warm-up (IMW)
Number of subjects: 17
Study 30640308 — intervention group
Group type: COMPARATOR
Intervention: Sham IMW (CON)
Number of subjects: 17
Study 31999170 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT) group
Number of subjects: 200
Study 31999170 — intervention group
Group type: COMPARATOR
Intervention: Episodic Recent Thinking (ERT) control group
Number of subjects: 200
Study 31219000 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavalent antimony (Sbv) + Pentoxifylline (PTX)
Number of subjects: 0
Study 31219000 — intervention group
Group type: COMPARATOR
Intervention: Pentavalent antimony (Sbv)
Number of subjects: 0
Study 28814096 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot popliteal fossa block (PFB)
Number of subjects: 167
Study 28814096 — intervention group
Group type: COMPARATOR
Intervention: Ankle block (AB)
Number of subjects: 167
Study 25144134 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body strength (LBS) group performing resistance and power-oriented training (full squat, split squat, CMJ loaded, CMJ) twice per week in addition to in-water training
Number of subjects: 21
Study 25144134 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) doing in-water training only
Number of subjects: 21
Study 23937552 — intervention group
Group type: EXPERIMENTAL
Intervention: Single incision laparoscopic surgery (SILS)
Number of subjects: 149
Study 23937552 — intervention group
Group type: COMPARATOR
Intervention: Multiport laparoscopic surgery (MLS)
Number of subjects: 149
Study 22036640 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided aspiration
Number of subjects: 60
Study 22036640 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic-guided aspiration
Number of subjects: 60
Study 22036640 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ultrasound-guided aspiration and C-reactive protein
Number of subjects: 60
Study 19255036 — intervention group
Group type: EXPERIMENTAL
Intervention: Head cooling for 72 hours starting within 6 hours of birth, rectal temperature maintained at 34.5 degrees C +/- 0.5 degrees C
Number of subjects: 230
Study 19255036 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 230
Study 17605489 — intervention group
Group type: EXPERIMENTAL
Intervention: Onplant installation
Number of subjects: 120
Study 17605489 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthosystem implant installation
Number of subjects: 120
Study 17605489 — intervention group
Group type: COMPARATOR
Intervention: Premolar extraction
Number of subjects: 120
Study 14716650 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA plus TENS
Number of subjects: 3
Study 14716650 — intervention group
Group type: COMPARATOR
Intervention: PCA plus sham TENS
Number of subjects: 3
Study 14716650 — intervention group
Group type: COMPARATOR
Intervention: PCA alone
Number of subjects: 3
Study 11226108 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 40
Study 11226108 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.75%
Number of subjects: 40
Study 9552948 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system
Number of subjects: 56
Study 9552948 — intervention group
Group type: COMPARATOR
Intervention: Control group (current medical treatment)
Number of subjects: 56
Study 7798982 — intervention group
Group type: EXPERIMENTAL
Intervention: Milan Overall Dementia Assessment (MODA)
Number of subjects: 312
Study 3393937 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercessory prayer (IP) by participating Christians praying outside the hospital
Number of subjects: 393
Study 3393937 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intercessory prayer)
Number of subjects: 393
Study 1193075 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 wk high intensity, low repetition strength conditioning programme
Number of subjects: 100
Study 1193075 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivity periods of 1, 4, 6, and 8 wk
Number of subjects: 100
Study 1193075 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 wk of detraining
Number of subjects: 100
Study 1193075 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining of 4, 6, and 8 wk
Number of subjects: 100
Study 1193075 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivity periods of 6 and 8 wk
Number of subjects: 100
Study 1193075 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 31607172 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious gaming based on transferring information, priming and evaluative conditioning for half an hour
Number of subjects: 81
Study 31607172 — intervention group
Group type: COMPARATOR
Intervention: Non-health‐related computer games
Number of subjects: 81
Study 31484710 — intervention group
Group type: COMPARATOR
Intervention: ocrelizumab (600 mg)
Number of subjects: 0
Study 28118402 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Renin Inhibition (DRI; aliskiren 300 mg/day)
Number of subjects: 15
Study 28118402 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin Converting Enzyme Inhibition (ACEi; ramipril 10 mg/day)
Number of subjects: 15
Study 25952550 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) training program (12-week, 14-hour)
Number of subjects: 17
Study 25952550 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 17
Study 23557331 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-message reminders
Number of subjects: 6450
Study 23557331 — intervention group
Group type: COMPARATOR
Intervention: Telephone reminders
Number of subjects: 6450
Study 21208354 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg
Number of subjects: 1250
Study 21208354 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg
Number of subjects: 1250
Study 21208354 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 1250
Study 19141573 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity Participation Questionnaire (APaQ)
Number of subjects: 1043
Study 17339133 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast temperature water therapy
Number of subjects: 20
Study 17339133 — intervention group
Group type: COMPARATOR
Intervention: Active recovery
Number of subjects: 20
Study 15274095 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP-CFC aerosol (>or= 500 mcg/day) via nasal inhalation
Number of subjects: 75
Study 15274095 — intervention group
Group type: COMPARATOR
Intervention: 200 mcg/day of aqueous intranasal beclomethasone plus oral inhalation of BDP-CFC (>or= 500 mcg/day)
Number of subjects: 75
Study 11373466 — intervention group
Group type: EXPERIMENTAL
Intervention: Afelimomab
Number of subjects: 446
Study 11373466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 446
Study 11373466 — intervention group
Group type: COMPARATOR
Intervention: Nonrandomized patients
Number of subjects: 446
Study 9127135 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron alone
Number of subjects: 85
Study 9127135 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone plus granisetron
Number of subjects: 85
Study 9127135 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide alone
Number of subjects: 85
Study 8088931 — intervention group
Group type: EXPERIMENTAL
Intervention: doxofylline 800 mg b.i.d.
Number of subjects: 48
Study 8088931 — intervention group
Group type: EXPERIMENTAL
Intervention: theophylline slow-release 400 mg b.i.d.
Number of subjects: 48
Study 8088931 — intervention group
Group type: EXPERIMENTAL
Intervention: bamifylline 1200 mg b.i.d.
Number of subjects: 48
Study 3318434 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg of nabumetone as a single bedtime dose
Number of subjects: 332
Study 3318434 — intervention group
Group type: COMPARATOR
Intervention: 900 mg of aspirin in four divided doses
Number of subjects: 332
Study 29470685 — intervention group
Group type: EXPERIMENTAL
Intervention: Halogen light stimulation
Number of subjects: 598
Study 29470685 — intervention group
Group type: COMPARATOR
Intervention: No light stimulation
Number of subjects: 598
Study 26658441 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiosurgery (22 Gy margin dose, follow-up 86 months)
Number of subjects: 509
Study 26658441 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiosurgery
Number of subjects: 509
Study 24631386 — intervention group
Group type: EXPERIMENTAL
Intervention: Yacon flour (0.14 g of fructooligosaccharides/kg of body weight daily) for 18 weeks
Number of subjects: 117
Study 24631386 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study 24631386 — intervention group
Group type: EXPERIMENTAL
Intervention: Yacon flour
Number of subjects: 117
Study 24631386 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 117
Study 23035743 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea catechin (GTC) supplementation (630.9 mg GTC daily, n=26)
Number of subjects: 52
Study 23035743 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=26)
Number of subjects: 52
Study 20836779 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotaped practice and feedback
Number of subjects: 34
Study 18039889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paging system for memory and planning problems after brain injury
Number of subjects: 36
Study 18039889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paging system for TBI participants
Number of subjects: 36
Study 18039889 — intervention group
Group type: COMPARATOR
Intervention: CVA participants
Number of subjects: 36
Study 15962683 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiver of consent for retrospective chart reviews
Number of subjects: 0
Study 15962683 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiver of consent for prospective observational studies
Number of subjects: 0
Study 15962683 — intervention group
Group type: COMPARATOR
Intervention: Randomized clinical trials
Number of subjects: 0
Study 12884343 — intervention group
Group type: EXPERIMENTAL
Intervention: Total laryngectomy with pharyngeal neurectomy (PN)
Number of subjects: 45
Study 12884343 — intervention group
Group type: COMPARATOR
Intervention: Total laryngectomy without pharyngeal neurectomy (C)
Number of subjects: 45
Study 12923650 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (500 I.U. D‐alpha‐tocopherol)
Number of subjects: 13
Study 12923650 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 13
Study 9477148 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB)
Number of subjects: 23
Study 9477148 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 23
Study 9477148 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 23
Study 7533461 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (10 mg/d)
Number of subjects: 120
Study 7533461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 2529375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 5 mg orally
Number of subjects: 20
Study 2529375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21677 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam
Number of subjects: 97
Study 21677 — intervention group
Group type: COMPARATOR
Intervention: Althesin
Number of subjects: 97
Study 31099141 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine (20 mg)
Number of subjects: 22
Study 31099141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 28186540 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose continuous erythropoiesis receptor activator (CERA; monthly dose 30–75 µg)
Number of subjects: 235
Study 28186540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study 28186540 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose continuous erythropoiesis receptor activator (CERA)
Number of subjects: 235
Study 24859614 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal exercises (Group 1)
Number of subjects: 27
Study 24859614 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2)
Number of subjects: 27
Study 23247045 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with steroids plus pentostatin, mycophenolate mofetil, etanercept, or denileukin diftitox
Number of subjects: 0
Study 21839033 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cosmetic product containing various active ingredients of botanical origin
Number of subjects: 0
Study 19797281 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care with cooling to 33.5 degrees C for 72 hours
Number of subjects: 325
Study 19797281 — intervention group
Group type: COMPARATOR
Intervention: Intensive care alone
Number of subjects: 325
Study 16691086 — intervention group
Group type: EXPERIMENTAL
Intervention: Genuine acupuncture needle
Number of subjects: 41
Study 16691086 — intervention group
Group type: COMPARATOR
Intervention: Sham needle
Number of subjects: 41
Study 14631163 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% sucrose
Number of subjects: 0
Study 14631163 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 0
Study 11780330 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (6.25 mg to 25 mg t.i.d.)
Number of subjects: 822
Study 11780330 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 822
Study 9032180 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum from asthmatic subjects
Number of subjects: 0
Study 8515495 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment with high-dose chemotherapy (cyclophosphamide 1875 mg/m2, cisplatin 55 mg/m2, carmustine 600 mg/m2) followed by autologous bone marrow reinfusion.
Number of subjects: 39
Study 8515495 — intervention group
Group type: COMPARATOR
Intervention: Observation until relapse followed by the same high-dose chemotherapy and autologous bone marrow reinfusion.
Number of subjects: 39
Study 8515495 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms (immediate treatment and observation)
Number of subjects: 39
Study 31453883 — intervention group
Group type: EXPERIMENTAL
Intervention: aTDCS (1.5 mA for 18 min) with eccentric exercise
Number of subjects: 26
Study 31453883 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation with eccentric exercise
Number of subjects: 26
Study 29224059 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless suture button device
Number of subjects: 54
Study 29224059 — intervention group
Group type: COMPARATOR
Intervention: Syndesmotic screw fixation
Number of subjects: 54
Study 27579536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tivantinib (MET inhibitor)
Number of subjects: 102
Study 27579536 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline circulating MET
Number of subjects: 102
Study 27579536 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline circulating HGF
Number of subjects: 102
Study 27579536 — intervention group
Group type: EXPERIMENTAL
Intervention: AFP
Number of subjects: 102
Study 27579536 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF
Number of subjects: 102
Study 27579536 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 102
Study 24990455 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (lecture, posters, pocket protocols) at hospital 1
Number of subjects: 109
Study 24990455 — intervention group
Group type: COMPARATOR
Intervention: Control group (hospital 2, merely informed of the audit)
Number of subjects: 109
Study 22378334 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding (BF)
Number of subjects: 338
Study 22378334 — intervention group
Group type: COMPARATOR
Intervention: Formula feeding (FF)
Number of subjects: 338
Study 20698216 — intervention group
Group type: EXPERIMENTAL
Intervention: roxatidine acetate 75 mg twice daily (n = 16)
Number of subjects: 33
Study 20698216 — intervention group
Group type: COMPARATOR
Intervention: omeprazole 20 mg once daily (n = 17)
Number of subjects: 33
Study 18209165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone
Number of subjects: 19
Study 18209165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 18209165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone (after switching from placebo)
Number of subjects: 19
Study 18209165 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 19
Study 15880021 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with reduced-exposure cyclosporine
Number of subjects: 3
Study 15880021 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus dose reduction
Number of subjects: 3
Study 15880021 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose furosemide
Number of subjects: 3
Study 15880021 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 3
Study 15880021 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidine-iodine instillations
Number of subjects: 3
Study 15880021 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 3
Study 12682838 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (VC)
Number of subjects: 16
Study 12682838 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 16
Study 11219598 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser angioplasty
Number of subjects: 308
Study 11219598 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 308
Study 9062051 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (running 9.6 km in an hour)
Number of subjects: 8
Study 9062051 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 8
Study 2004922 — intervention group
Group type: EXPERIMENTAL
Intervention: Milking protocol
Number of subjects: 200
Study 2004922 — intervention group
Group type: EXPERIMENTAL
Intervention: Stripping protocol
Number of subjects: 200
Study 2004922 — intervention group
Group type: COMPARATOR
Intervention: No manipulation (first 8 hours)
Number of subjects: 200
Study 6734422 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam 0.5 mg
Number of subjects: 0
Study 6734422 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam 1.0 mg
Number of subjects: 0
Study 6734422 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam 2.0 mg
Number of subjects: 0
Study 6734422 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 5 mg
Number of subjects: 0
Study 30584136 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (caregivers)
Number of subjects: 226
Study 30584136 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 226
Study 30314463 — intervention group
Group type: EXPERIMENTAL
Intervention: Heteroscedastic partially nested mixed-effects model
Number of subjects: 0
Study 30314463 — intervention group
Group type: COMPARATOR
Intervention: Fully clustered mixed effects models
Number of subjects: 0
Study 30314463 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially nested mixed-effects models
Number of subjects: 0
Study 30314463 — intervention group
Group type: EXPERIMENTAL
Intervention: All models assessed
Number of subjects: 0
Study 26520208 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation techniques
Number of subjects: 59
Study 26520208 — intervention group
Group type: COMPARATOR
Intervention: Control group (information-based training courses)
Number of subjects: 59
Study 24931393 — intervention group
Group type: EXPERIMENTAL
Intervention: New-onset atrial fibrillation (Group 1)
Number of subjects: 2392
Study 21655910 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible light-cured resin (VLCR) denture base material
Number of subjects: 90
Study 21655910 — intervention group
Group type: COMPARATOR
Intervention: Polymethylmethacrylate (PMMA) denture acrylic
Number of subjects: 90
Study 20181388 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium disilicate glass-ceramic restorations
Number of subjects: 32
Study 20181388 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucite reinforced glass-ceramic restorations
Number of subjects: 32
Study 20181388 — intervention group
Group type: COMPARATOR
Intervention: Different preparation designs (non-retentive, occlusal preparation with chamfer or straight-beveled finishing line)
Number of subjects: 32
Study 20181388 — intervention group
Group type: COMPARATOR
Intervention: Design of the finishing line
Number of subjects: 32
Study 17682090 — intervention group
Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/d)
Number of subjects: 389
Study 17682090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 15737442 — intervention group
Group type: EXPERIMENTAL
Intervention: Total lumbar disc replacement
Number of subjects: 29
Study 12087568 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa administered IV once weekly
Number of subjects: 507
Study 12087568 — intervention group
Group type: COMPARATOR
Intervention: Epoetin administered IV three times weekly
Number of subjects: 507
Study 9468804 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise during learning and recall
Number of subjects: 0
Study 9468804 — intervention group
Group type: COMPARATOR
Intervention: Rest during learning and recall
Number of subjects: 0
Study 9468804 — intervention group
Group type: EXPERIMENTAL
Intervention: Changed state conditions (exercise to rest or rest to exercise)
Number of subjects: 0
Study 8585775 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg trimethoprim and 800 mg sulfamethoxazole twice a day
Number of subjects: 60
Study 8585775 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg ciprofloxacin twice a day
Number of subjects: 60